Mirador Capital Partners’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Mirador Capital Partners’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-29,195	Closed	-$10K	–	135
2016 Q3	$10K	Buy	+29,195	New	+$10K	0.01%	107

Mirador Capital Partners's RXII Position: Q4 2016 in Review

Mirador Capital Partners sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 29,195 shares — an estimated $10K sold.

Mirador Capital Partners first reported a position in RXII in Q3 2016 and held it in 1 quarter. The position peaked at $10K in Q3 2016. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Mirador Capital Partners reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Mirador Capital Partners sold 29,195 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $10K.
Mirador Capital Partners first reported a position in GALENA BIOPHARMA INC COM in Q3 2016 and held it in 1 quarter.
Mirador Capital Partners's GALENA BIOPHARMA INC COM position peaked at $10K in Q3 2016.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Mirador Capital Partners's 13F filing for Q4 2016, filed 13 Feb 2017.